Summary
Little is known about the epidemiology of cardiac disease in diabetic end-stage renal disease. We therefore prospectively followed a cohort of 433 patients who survived 6 months after the inception of dialysis therapy for an average of 41 months. Clinical and echocardiographic data were collected yearly. At baseline, diabetic patients (n = 116) had more echocardiographic concentric left ventricular hypertrophy (50 vs 38 %, p = 0.04), clinically diagnosed ischaemic heart disease (32 vs 18%, p = 0.003) and cardiac failure (48 vs 24%, p < 0.00001) than non-diabetic patients (n = 317). After adjusting for age and sex, diabetic patients had similar rates of progression of echocardiographic disorders, and de novo cardiac failure, but higher rates of de novo clinically diagnosed ischaemic heart disease (RR 3.2, p = 0.0002), overall mortality (RR 2.3, p < 0.0001) and cardiovascular mortality (RR 2.6, p < 0.0001) than non-diabetic patients. Mortality was higher in diabetic patients following admission for clinically diagnosed ischaemic heart disease (RR 1.7, p = 0.05) and cardiac failure (RR 2.2, p = 0.0003). Among diabetic patients older age, left ventricular hypertrophy, smoking, clinically diagnosed ischaemic heart disease, cardiac failure and hypoalbuminaemia were independently associated with mortality. The excessive cardiac morbidity and mortality of diabetic patients seem to be mediated via ischaemic disease, rather than progression of cardiomyopathy while on dialysis therapy. Potentially remediable risk factors include smoking, left ventricular hypertrophy, and hypoalbuminaemia.
Article PDF
Similar content being viewed by others
Abbreviations
- ESRD:
-
End-stage renal disease
- LV:
-
left ventricular
References
Perneger TV, Brancati FL, Whelton PK, Klag MJ (1994) End-stage renal disease attributable to diabetes mellitus. Ann Intern Med 121: 912–918
United States Renal Data System. USRDS (1995)Annual Report. US Department of Health and Human Services, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease: the Framingham Study. JAMA 241: 2035–2038
Valsania P, Zarich SW, Kowalhuk GJ, Kosinski E, Warram JH, Krowelski AS (1991) Severity of coronary artery disease in young patients with insulin-dependent diabetes mellitus. Am Heart J 122: 695–700
Kannel WB, Hjortland MC, Castelli WP (1974) Role of diabetes in congestive heart failure: the Framingham Study. Am J Cardiol 34: 29–34
Foley RN, Parfrey PS, Harnett JD, et al. (1995) Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47: 186–192
Harnett JD, Foley RN, Kent GM, Barre PN, Murray D (1995) Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 47: 884–890
Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1995) The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 5: 2024–2031
Parfrey PS, Harnett JD, Foley RN, et al. (1995) Impact of renal transplantation on uremic cardiomyopathy. Transplantation 15: 908–914
Foley RN, Parfrey PS, Harnett JD, et al. (1996) Hypocalcemia, morbidity and mortality in end-stage renal disease. Am J Nephrol 16: 386–393
Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1996) The impact of anemia on cardiomyopathy, morbidity and mortality in end-stage renal disease. Am J Kidney Dis 28: 53–61
Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1996) Hypoalbuminemia, cardiac morbidity and mortality in end-stage renal disease. J Am Soc Nephrol 7: 728–736
Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1996) The impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 49: 1379–1385
Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE (1996) Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 11: 1277–1285
Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE (1996) Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int 49: 1428–1434
Devereux RB, Alonso DR, Lutas EM, et al. (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57: 450–458
Pombo JF, Troy BL, Russell RO Jr (1971) Left ventricular volumes and ejection fractions by echocardiography. Circulation 43: 480–490
Levy D, Savage DD, Garrison RJ, et al. (1987) Echocardiographic criteria for left ventricular hypertrophy: the Framingham Study. Am J Cardiol 59: 956–960
Huwez FU, Pringle SD, Macfarlane PW (1992) A new classification of left ventricular geometry based on M-mode echocardiography. Am J Cardiol 70: 681–688
Manske CL, Wang Y, Rector T, Wilson RF, White CW (1992) Coronary revascularization in insulin-dependent diabetic patients with chronic renal failure. Lancet 340: 998–1002
Schultz R (1876) Advanced cardiac insufficiency, a frequent complication of diabetes mellitus, requiring attention. Berl Klinische Wochen Schrift 6: 4–5
Blumental HT, Alex M, Goldenberg S (1960) A study of lesions of the intramural coronary by branches in diabetes mellitus. Arch Pathol 70: 27–42
Zoneraich S, Silverman G (1978) Myocardial small vessel disease in diabetic patients. In: Zoneraich S (ed) Diabetes and the Heart, Charles C Thomas, Springfield pp 3–18
Shapiro LM, Howatt AP, Calter MM (1981) Left ventricular function in diabetes mellitus I. Methodology and prevalence and spectrum of abnormalities. Br Heart J 45 122–128
Shapiro LM, Leatherdale BA, MacKinnon J, et al. (1981) Left ventricular function in diabetes mellitus II. Relation between clinical features and left ventricular function. Br Heart J 45: 129–132
Theusen L, Christiansen JS, Mogensen CE, et al. (1988) Echocardiographic-determined left ventricular wall characteristics in insulin dependent diabetic patients. Acta Med Scand 224: 343–348
Galderisi M, Anderson KM, Wilson PWF, et al. (1991) Echocardiographic evidence for a distinct diabetic cardiomyopathy (The Framingham Heart Study). Am J Cardiol 68: 85–89
Weinrauch LA, D’Elia JA, Gleason RE, et al. (1992) Usefulness of left ventricular size and function in predicting survival in chronic dialysis patients with diabetes mellitus. Am J Cardiol 70: 300–303
Manske CL, Thomas W, Wang Y, Wilson RF (1992) Screening diabetic transplant candidates for coronary artery disease: identification of a low-risk subgroup. Kidney Int 44: 617–621
McMillan MA, Briggs JD, Junor BS (1990) Outcome of renal replacement therapy in patients with diabetes mellitus. BMJ 301: 540–544
Manske CL, Wilson RF, Wang Y, Thomas W (1992) Prevalence of and risk factors for angiographically determined coronary artery disease in type-1 diabetic patients with nephropathy. Arch Intern Med 152: 2450–2455
Yudkin JS (1993) How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects. BMJ 306: 1313–1318
Koch M, Thomas B, Tschope W, Ritz E (1993) Survival and predictors of death in dialysed diabetic patients. Diabetologia 36: 1113–1117
Tschope W, Koch M, Thomas B, Ritz E (1994) Serum lipids predict cardiac death in diabetic patients on maintenance haemodialysis. Results of a prospective study. The German Study Group Diabetes and Uremia. Nephron 64: 354–358
Lowrie EG, Lew NL, Huang WH (1992) Race and diabetes as death predictors in haemodialysis patients. Kidney Int Suppl 38:S22-S31
Collins AJ (1993) How can the mortality rate of chronic dialysis patients be reduced? Semin Dial 6: 102
Makita Z, Bucala R, Rayfield EJ, et al. (1994) Reactive glcosylation end-products in diabetic uremia. Lancet 343: 1519–1522
Gentil MA, Carriazzo A, Pavon MI, et al. (1991) Comparison of survival in continuous ambulatory peritoneal dialysis and hospital haemodialysis: a multicentric study. Nephrol Dial Transplant 6: 444–451
Maiorca R, Vonesh E, Cancarini GC, et al. (1991) A multicenter, selection-adjusted comparison of patient and technique survivals among CAPD and haemodialysis. Periton Dial Int 11: 118–127
Held PJ, Port FK, Turenne MN, Gaylin DS, Hamburger RJ, Wolfe RA (1994) Continuous ambulatory peritoneal dialysis and haemodialysis: a comparison of patient mortality with adjustment for comorbid conditions. Kidney Int 45: 1163–1169
Bloembergen W, Port FK, Mauger EA, Wolfe RA (1995) A comparison of mortality between patients treated with haemodialysis and peritoneal dialysis. J Am Soc Nephrol 6: 177–183
Lowrie EG, Huang WH, Lew N (1995) Death risk predictors among peritoneal and haemodialysis patients: a preliminary comparison. Am J Kidney Dis 26: 220–228
Disney AP (1995) Demography and survival of patients receiving treatment for chronic renal failure in Australia and New Zealand: report on dialysis and renal transplantation treatment from the Australia and New Zealand Dialysis and Transplant Registry. Am J Kidney Dis 25: 165–175
Fenton S, Desmeules M, Copleston P, et al. (1995) Renal replacement therapy in Canada: a report from the Canadian Organ Replacement Registry. Am J Kidney Dis 25: 134–150
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Foley, R.N., Culleton, B.F., Parfrey, P.S. et al. Cardiac disease in diabetic end-stage renal disease. Diabetologia 40, 1307–1312 (1997). https://doi.org/10.1007/s001250050825
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/s001250050825